Anti-Androgen Therapy in Polyendocrine Metabolic Ovary Syndrome (PMOS, Formerly PCOS): Efficacy, Safety, and Phenotype-Oriented Clinical Decision-Making

    July 2026 in “ Journal of Ovarian Research ”
    Hongfa Peng, Jingjing Jiang, Zi Wang, Wei Wang
    Studysummary In this review, researchers provided a comprehensive analysis of anti-androgen therapies for polyendocrine metabolic ovarian syndrome (PMOS/PCOS), examining their efficacy and safety while proposing a phenotype-guided management framework and highlighting research gaps, such as long-term cardiovascular safety and predictive biomarkers.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →